School level of children carrying a HNF1B variant or a deletion.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
01 2020
Historique:
received: 18 12 2017
accepted: 16 07 2019
revised: 02 07 2019
pubmed: 5 9 2019
medline: 4 2 2021
entrez: 5 9 2019
Statut: ppublish

Résumé

The prevalence of neurological involvement in patients with a deletion of or a variant in the HNF1B gene remains discussed. The aim of this study was to investigate the neuropsychological outcomes in a large cohort of children carrying either a HNF1B whole-gene deletion or a disease-associated variant, revealed by the presence of kidney anomalies. The neuropsychological development-based on school level-of 223 children included in this prospective cohort was studied. Data from 180 children were available for analysis. Patients mean age was 9.6 years, with 39.9% of girls. Among these patients, 119 carried a HNF1B deletion and 61 a disease-associated variant. In the school-aged population, 12.7 and 3.6% of patients carrying a HNF1B deletion and a disease-associated variant had special educational needs, respectively. Therefore, the presence of a HNF1B deletion increases the risk to present with a neuropsychiatric involvement when compared with the general population. On the other hand, almost 90% of patients carrying a HNF1B disease-associated variant or deletion have a normal schooling in a general educational environment. Even if these findings do not predict the risk of neuropsychiatric disease at adulthood, most patients diagnosed secondary to kidney anomalies do not show a neurological outcome severe enough to impede standard schooling at elementary school. These results should be taken into account in prenatal counseling.

Identifiants

pubmed: 31481685
doi: 10.1038/s41431-019-0490-6
pii: 10.1038/s41431-019-0490-6
pmc: PMC6906503
doi:

Substances chimiques

HNF1B protein, human 0
Hepatocyte Nuclear Factor 1-beta 138674-15-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-63

Références

Barbacci E. Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development. 1999;126AD:4795–805. 11.
El-Khairi R, Vallier L. The role of hepatocyte nuclear factor 1β in disease and development. Diabetes Obes Metab. 2016;18:23–32.
doi: 10.1111/dom.12715
Heidet L, Decramer S, Pawtowski A, Moriniere V, Bandin F, Knebelmann B, et al. Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol. 2010;5:1079–90.
doi: 10.2215/CJN.06810909
Laffargue F, Bourthoumieu S, Llanas B, Baudouin V, Lahoche A, Morin D, et al. Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome. Arch Dis Child. 2015;100:259–64.
doi: 10.1136/archdischild-2014-306810
Moreno-De-Luca D, Mulle JG, Kaminsky EB, Sanders SJ, Myers SM, Adam MP, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet. 2010;87:618–30.
doi: 10.1016/j.ajhg.2010.10.004
Rasmussen M, Vestergaard EM, Graakjaer J, Petkov Y, Bache I, Fagerberg C, et al. 17q12 deletion and duplication syndrome in Denmark—a clinical cohort of 38 patients and review of the literature. Am J Med Genet Part A. 2016 http://doi.wiley.com/10.1002/ajmg.a.37848 . Accessed 23 Aug 2016.
Chen C-P, Chang S-D, Wang T-H, Wang L-K, Tsai J-D, Liu Y-P, et al. Detection of recurrent transmission of 17q12 microdeletion by array comparative genomic hybridization in a fetus with prenatally diagnosed hydronephrosis, hydroureter, and multicystic kidney, and variable clinical spectrum in the family. Taiwan J Obstet Gynecol. 2013;52:551–7.
doi: 10.1016/j.tjog.2013.10.017
Clissold RL, Shaw-Smith C, Turnpenny P, Bunce B, Bockenhauer D, Kerecuk L, et al. Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder. Kidney Int. 2016 http://www.sciencedirect.com/science/article/pii/S0085253816301156 . Accessed 23 Aug 2016.
Dubois-Laforgue D, Bellanné-Chantelot C, Charles P, Jacquette A, Larger E, Ciangura C, et al. Intellectual disability in patients with MODY due to hepatocyte nuclear factor 1B (HNF1B) molecular defects. Diabetes Metab. 2017;43:89–92.
doi: 10.1016/j.diabet.2016.10.003
Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. New Engl J Med. 2012;367:1321–31.
doi: 10.1056/NEJMoa1200395
Decramer S, Parant O, Beaufils S, Clauin S, Guillou C, Kessler S, et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol. 2007;18:923–33.
doi: 10.1681/ASN.2006091057
Bellanne-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, et al. Large genomic rearrangements in the hepatocyte nuclear factor-1 (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54:3126–32.
doi: 10.2337/diabetes.54.11.3126
Sequence Variant Nomenclature. https://varnomen.hgvs.org/bg-material/basics/ . Accessed 19 Jun 2019.
Rosenwald F. Repères et références statistiques sur les enseignements, la formation et la recherche 2018. education.gouv.fr: 2018. http://www.education.gouv.fr/cid57096/reperes-et-references-statistiques.html . Accessed 23 Dec 2018.
Loirat C, Bellanne-Chantelot C, Husson I, Deschenes G, Guigonis V, Chabane N. Autism in three patients with cystic or hyperechogenic kidneys and chromosome 17q12 deletion. Nephrol Dial Transpl. 2010;25:3430–3.
doi: 10.1093/ndt/gfq380
Abellán A, Vernier B, Rétaux S, Medina L. Similarities and differences in the forebrain expression of Lhx1 and Lhx5 between chicken and mouse: Insights for understanding telencephalic development and evolution. J Comp Neurol. 2010;518:3512–28.
doi: 10.1002/cne.22410
Girirajan S, Dennis MY, Baker C, Malig M, Coe BP, Campbell CD, et al. Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. Am J Hum Genet. 2013;92:221–37.
doi: 10.1016/j.ajhg.2012.12.016
Bae C-J, Jeong J, Saint-Jeannet J-P. A novel function for Egr4 in posterior hindbrain development. Sci Rep. 2015;5:7750.
doi: 10.1038/srep07750
Wiellette EL. vhnf1 and Fgf signals synergize to specify rhombomere identity in the zebrafish hindbrain. Development. 2003;130:3821–9.
doi: 10.1242/dev.00572
Makki N, Capecchi MR. Identification of novel Hoxa1 downstream targets regulating hindbrain, neural crest and inner ear development. Dev Biol. 2011;357:295–304.
doi: 10.1016/j.ydbio.2011.06.042
Clissold RL, Ashfield B, Burrage J, Hannon E, Bingham C, Mill J, et al. Genome-wide methylomic analysis in individuals with HNF1B intragenic mutation and 17q12 microdeletion. Clin Epigenetics . 2018;10. https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-018-0530-z . Accessed 26 Dec 2018.
Gilboa Y, Perlman S, Pode-Shakked N, Pode-Shakked B, Shrim A, Azaria-Lahav E, et al. Prenatal diagnosis of 17q12 deletion syndrome: from fetal hyperechogenic kidneys to high risk for autism: prenatal echogenic kidneys and autism in 17q12 deletions. Prenat Diagn 2016;36:1027–32.
doi: 10.1002/pd.4926

Auteurs

Fanny Laliève (F)

Service de Pédiatrie, CHU de Limoges, Limoges, France. lalieve.fanny@gmail.com.

Stéphane Decramer (S)

Service de Néphrologie Pédiatrique, CHU de Toulouse, Toulouse, France.

Laurence Heidet (L)

Service de Néphrologie Pédiatrique, Hôpital Necker, APHP, Paris, France.

Véronique Baudouin (V)

Service de Néphrologie Pédiatrique, Hôpital Robert Debré, APHP, Paris, France.

Annie Lahoche (A)

Service de Néphrologie Pédiatrique, CHU Jeanne de Flandres, Lille, France.

Brigitte Llanas (B)

Service de Néphrologie Pédiatrique, CHU de Bordeaux, Bordeaux, France.

Pierre Cochat (P)

Service de Néphrologie Pédiatrique, Hôpital Femme Mère Enfant, Lyon, France.

Julie Tenenbaum (J)

Service de Néphrologie Pédiatrique, CHU de Montpellier, Montpellier, France.

Marie-Pierre Lavocat (MP)

Service de Néphrologie Pédiatrique, CHU de Saint-Etienne, Saint-Etienne, France.

Philippe Eckart (P)

Service de Néphrologie Pédiatrique, CHU de Caen, Caen, France.

Françoise Broux (F)

Service de Néphrologie Pédiatrique, CHU de Rouen, Rouen, France.

Gwenaelle Roussey (G)

Service de Néphrologie Pédiatrique, CHU de Nantes, Nantes, France.

Sylvie Cloarec (S)

Service de Néphrologie Pédiatrique, CHU de Tours, Tours, France.

Isabelle Vrillon (I)

Service de Néphrologie Pédiatrique, CHU de Nancy, Nancy, France.

Olivier Dunand (O)

Service de Néphrologie Pédiatrique, CHU de la Réunion, Saint-Denis, France.

Lucie Bessenay (L)

Service de Néphrologie Pédiatrique, CHU de Clermont, Clermont-Ferrand, France.

Michel Tsimaratos (M)

Service de Néphrologie Pédiatrique, CHU de Marseille, Marseille, France.

François Nobili (F)

Service de Néphrologie Pédiatrique, CHU de Besançon, Besançon, France.

Christine Pietrement (C)

Service de Néphrologie Pédiatrique, CHU de Reims, Reims, France.

Loïc De Parscau (L)

Service de Pédiatrie, CHU de Brest, Brest, France.

Valérie Bonneville (V)

Service de Pédiatrie, CH de Chollet, Chollet, France.

Nicolas Rodier (N)

CIC 1435, CHU de Limoges, Limoges, France.

Cécile Saint-Martin (C)

Département de génétique, Assistance Publique-Hôpitaux de Paris (AP-HP) Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Sorbonne Université, Paris, France.

Nicolas Chassaing (N)

CHU Toulouse, Service de Génétique Médicale, Hôpital Purpan, Toulouse, France.

Laurence Michel-Calemard (L)

Service de Biochimie Biologie Moléculaire Grand Est; UM Pathologies Endocriniennes, Rénales, Musculaires et Mucoviscidose; LBMMS, Hospices Civils de Lyon, Bron, France.

Vincent Moriniere (V)

Service de Génétique, Hôpital Necker, APHP, Paris, France.

Christine Bellanné-Chantelot (C)

Département de génétique, Assistance Publique-Hôpitaux de Paris (AP-HP) Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Sorbonne Université, Paris, France.

Claire Bahans (C)

Service de Pédiatrie, CHU de Limoges, Limoges, France.

Vincent Guigonis (V)

Service de Pédiatrie, CHU de Limoges, Limoges, France. vincent.guigonis@unilim.fr.
CIC 1435, CHU de Limoges, Limoges, France. vincent.guigonis@unilim.fr.
UMR CNRS 7276, Limoges, France. vincent.guigonis@unilim.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH